Human Orf with Immune-Mediated Reactions: A Systematic Review

被引:10
作者
Rossi, Luca [1 ,2 ]
Tiecco, Giorgio [1 ,2 ]
Venturini, Marina [3 ]
Castelli, Francesco [1 ,2 ]
Quiros-Roldan, Eugenia [1 ,2 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, Unit Infect & Trop Dis, I-25123 Brescia, Italy
[2] ASST Spedali Civili Brescia, I-25123 Brescia, Italy
[3] Univ Brescia, Dept Clin & Expt Sci, Sect Dermatol, I-25123 Brescia, Italy
关键词
Orf; ecthyma contagiosum; pustular dermatitis; bullous; autoimmune; erythema multiforme; pemphigoid; blister; systematic review; review; VIRUS-INFECTION; ERYTHEMA MULTIFORME; ANTIVIRAL ACTIVITY; INTERFERON-ALPHA; DISEASE; INJECTIONS; ACYCLOVIR; IMIQUIMOD; POXVIRUS; LESIONS;
D O I
10.3390/microorganisms11051138
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Orf is a highly contagious zoonosis caused by Orf virus (ORFV), which is endemic in sheep and goats worldwide. Human Orf is usually a self-limiting disease, but potential complications, including immune-mediated reactions, may occur. Methods: We included all articles regarding Orf-associated immunological complications published in peer-reviewed medical journals. We conducted a literature search of the United States National Library of Medicine, PubMed, MEDLINE, PubMed Central, PMC, and the Cochrane Controlled Trials. Results: A total of 16 articles and 44 patients were included, prevalently Caucasian (22, 95.7%) and female (22, 57.9%). The prevailing immunological reaction was erythema multiforme (26, 59.1%), followed by bullous pemphigoid (7, 15.9%). In most cases, the diagnosis was made on the basis of clinical and epidemiological history (29, 65.9%), while a biopsy of secondary lesions was performed in 15 patients (34.1%). A total of 12 (27.3%) patients received a local or systemic treatment for primary lesions. Surgical removal of primary lesion was described in two cases (4.5%). Orf-immune-mediated reactions were treated in 22 cases (50.0%), mostly with topical corticosteroids (12, 70.6%). Clinical improvement was reported for all cases. Conclusions: Orf-related immune reactions can have a varied clinical presentation, and it is important for clinicians to be aware of this in order to make a prompt diagnosis. The main highlight of our work is the presentation of complicated Orf from an infectious diseases specialist's point of view. A better understanding of the disease and its complications is essential to achieve the correct management of cases.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Immune-Mediated Neurological Disorders
    Teerin Liewluck
    Augusto Miravalle
    Current Neurology and Neuroscience Reports, 2015, 15
  • [22] Immune-mediated neutropenia in the neonate
    Maheshwari, A
    Christensen, RD
    Calhoun, DA
    ACTA PAEDIATRICA, 2002, 91 : 98 - 103
  • [23] Is fibromyalgia an immune-mediated disease?
    Trouvin, Anne-Priscille
    Perrot, Serge
    JOINT BONE SPINE, 2022, 89 (04)
  • [24] Microbiome in Immune-Mediated Uveitis
    Rodriguez-Fernandez, Carmen Antia
    Iglesias, Manuel Busto
    de Domingo, Begona
    Conde-Perez, Kelly
    Vallejo, Juan A.
    Rodriguez-Martinez, Lorena
    Gonzalez-Barcia, Miguel
    Llorenc, Victor
    Mondelo-Garcia, Cristina
    Poza, Margarita
    Fernandez-Ferreiro, Anxo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [25] Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders
    Yuasa, Akira
    Yonemoto, Naohiro
    Kamei, Kazumasa
    Murofushi, Toshiaki
    LoPresti, Michael
    Taneja, Ankush
    Horgan, Jake
    Ikeda, Shunya
    ADVANCES IN THERAPY, 2022, 39 (12) : 5327 - 5350
  • [26] Maternal steroid therapy for fetuses with immune-mediated complete atrioventricular block: a systematic review and meta-analysis
    Ciardulli, Andrea
    D'Antonio, Francesco
    Magro-Malosso, Elena Rita
    Saccone, Gabriele
    Manzoli, Lamberto
    Radolec, Mackenzy
    Berghella, Vincenzo
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (11) : 1884 - 1892
  • [27] Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis
    Cordero-Coma, Miguel
    Yilmaz, Taygan
    Onal, Sumru
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (01) : 12 - 20
  • [28] Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs
    Bestwick, Jason P.
    Skelly, Barbara J.
    Swann, James W.
    Glanemann, Barbara
    Bexfield, Nick
    Gkoka, Zeta
    Walker, David J.
    Silvestrini, Paolo
    Adamantos, Sophie
    Seth, Mayank
    Warland, James
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2022, 36 (04) : 1267 - 1280
  • [29] Immune-Mediated Myelopathies: A Review of Etiologies, Diagnostic Approach, and Therapeutic Management
    Abdel-Wahed, Lama
    Cho, Tracey A.
    SEMINARS IN NEUROLOGY, 2021, 41 (03) : 269 - 279
  • [30] Cytokines in Immune-mediated "Non-infectious" Uveitis
    Kalogeropoulos, Dimitrios
    Kanavaros, Panagiotis
    Vartholomatos, Georgios
    Moussa, George
    Ch'ng, Soon Wai
    Kalogeropoulos, Chris
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2025, 242 (01) : 31 - 46